Aug 30, 2022, 10:58 AM by

MMS Holdings, a data-focused contract research organization, announced the appointment of Kelly J. Hill to Chief Strategy Officer. This announcement comes as the company is accelerating in growth after its partnership with a private equity firm.

Aug 30, 2022, 08:00 AM by User Not Found

Bio-IT World | Lawmakers and animal welfare groups are calling for the FDA to abolish animal testing requirements for products under its jurisdiction.

Aug 30, 2022, 01:00 AM by User Not Found

Bio-IT World | AI-enabled drug discovery and sustainable development, a novel antitumor glioma platform, virtual reality operating theaters, and more.

Aug 26, 2022, 10:06 AM by

Aug 26, 2022, 10:05 AM by

Aug 26, 2022, 10:05 AM by

Aug 26, 2022, 10:04 AM by

Aug 26, 2022, 10:02 AM by

Aug 26, 2022, 10:01 AM by

Aug 25, 2022, 10:16 AM by

Aug 25, 2022, 10:15 AM by

Aug 25, 2022, 10:15 AM by

Aug 25, 2022, 10:15 AM by

Aug 25, 2022, 10:14 AM by

A leader in continuous remote patient monitoring and data analytics, physIQ today announced a strategic collaboration with InCarda Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company developing first-of-their-kind inhaled therapies for cardiovascular diseases. Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, recommended physIQ’s innovative monitoring solution to help advance InCarda’s clinical study of InRhythm™ (orally inhaled flecainide) in patients with atrial fibrillation (AF) – one of the most common heart arrhythmias that affects one in four adults over the age of 40.1

Aug 25, 2022, 10:13 AM by

Aug 25, 2022, 10:07 AM by

Aug 25, 2022, 01:00 AM by User Not Found

Bio-IT World | Researchers from the Wake Forest Institute for Regenerative Medicine and Wake Forest Organoid Research Center developed an immunoreactive tumor organoid to study microbial metabolites and their effect on immune function.

Aug 24, 2022, 09:45 AM by

GenScript ProBio announced that it has expanded its partnership with Athenex which is a leading biopharmaceutical business that is committed to the development, discovery and commercialization of innovative therapies to treat cancer and related disorders as well as the creation of cutting-edge treatments for gene and cell therapy with the benefit of a preferred collaboration.

Aug 24, 2022, 09:44 AM by

Aug 24, 2022, 08:00 AM by User Not Found

Bio-IT World | Though Parkinson’s is the second most common neurodegenerative disease, scientists know little about its etiology. Hoping to discover more, a research team at Simon Fraser University in Burnaby, British Columbia, developed a new fluorescence-based blood testing method to examine PD development and progression in neurons.